EUDA Health Holdings Ltd EUDA
mission is to make high-quality, personalized healthcare affordable and accessible for all its patients. It aims to provide one stop
healthcare and wellness services through its proprietary platform, EUDA. EUDA currently has operations in Singapore and has plans to
expand across Southeast Asia. Its operations in Singapore includes provision of medical urgent care and property management services.
January 2020, EUDA acquired 100% of the equity interests in Super Gateway Group Limited ("SGGL"), a property management service
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $6.8M | $4.0M | $3.7M | $3.8M | $4.6M | — |
| Cost of revenue | $3.8M | $3.2M | $2.9M | $2.9M | $3.3M | — |
| Gross profit | $3.0M | $762.2K | $842.1K | $870.0K | $1.2M | — |
| R&D | $249 | — | — | $17.2K | $129.3K | — |
| SG&A | $4.1M | $3.2M | $4.3M | $5.8M | $1.5M | — |
| Total operating expenses | $5.5M | $18.1M | $4.8M | $13.1M | $1.8M | — |
| Operating income | -$2.5M | -$17.3M | -$4.0M | -$12.2M | -$560.0K | — |
| Interest expense | $228.6K | $44.9K | $23.2K | — | — | — |
| Pre-tax income | -$2.7M | -$17.6M | -$8.4M | -$25.0M | $1.7M | — |
| Income tax | $41.9K | $4.4K | — | $20.8K | $46.5K | — |
| Net income | -$2.8M | -$15.4M | -$10.0M | -$24.9M | $864.8K | — |
| EPS, basic | -1.48 | -9.46 | -8.77 | -2.07 | 0.09 | — |
| EPS, diluted | -1.48 | -9.46 | -8.77 | -2.07 | 0.09 | — |
| Shares, diluted (wtd. avg.) | 1.9M | 1.6M | 1.1M | 12.0M | 9.3M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $345.1K | $237.6K | $189.0K | $57.5K | $190.0K | — |
| Receivables | $242.6K | $146.2K | $237.5K | $192.9K | $1.8M | — |
| Inventory | $2.8K | $129.0K | — | — | — | — |
| Total current assets | $1.0M | $762.9K | $723.4K | $25.0M | $4.4M | — |
| Property, plant and equipment | $137.3K | $87.7K | $6.7K | $11.5K | $56.9K | — |
| Goodwill | — | $0 | $0 | — | $992.7K | $1.0M |
| Other intangibles | $161.4K | $337.3K | — | — | $290.0K | — |
| Total assets | $1.7M | $1.7M | $1.3M | $25.6M | $8.0M | — |
| Accounts payable | $14.1K | $25.9K | $1.3K | $1.6M | $359.7K | — |
| Total current liabilities | $5.8M | $4.1M | $8.7M | $29.1M | $7.3M | — |
| Total liabilities | $6.0M | $4.3M | $8.8M | $29.1M | $7.4M | — |
| Retained earnings | -$52.9M | -$50.1M | -$34.7M | -$24.7M | $180.3K | — |
| Total equity | -$4.3M | -$2.6M | -$7.5M | -$3.5M | $600.0K | -$317.4K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$2.4M | -$2.0M | -$2.9M | -$1.5M | $443.9K | — |
| Depreciation and amortisation | $38.5K | $22.1K | $4.9K | $5.5K | $5.0K | — |
| Capital expenditure | $77.3K | $96.8K | — | $18.1K | $1.1K | — |
| Investing cash flow | -$104.5K | -$147.8K | — | -$268.2K | -$356.2K | — |
| Financing cash flow | $2.6M | $2.3M | $2.4M | $2.5M | -$168.4K | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-019361.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $4.6M | $3.8M | $3.7M | $4.0M | $6.8M |
| Gross profit | — | $1.2M | $870.0K | $842.1K | $762.2K | $3.0M |
| Net income | — | $864.8K | -$24.9M | -$10.0M | -$15.4M | -$2.8M |
Others in SIC 8000
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| LFST | LifeStance Health Group, Inc. | $4.94B | — | 13.9% |
| PRVA | Privia Health Group, Inc. | $2.86B | 124.5x | 22.3% |
| WGS | GeneDx Holdings Corp. | $1.67B | — | 40.0% |
| PNTG | Pennant Group, Inc. | $1.46B | 49.9x | 36.3% |
| USPH | U S PHYSICAL THERAPY INC /NV | $1.32B | 62.3x | 16.3% |
| INNV | InnovAge Holding Corp. | $1.30B | — | 11.8% |
| OMDA | Omada Health, Inc. | $1.16B | — | 53.2% |
| SRTA | Strata Critical Medical, Inc. | $412.3M | 9.3x | 34.3% |